Division of Pharmaceutical Chemistry and Technology , University of Helsinki , Viikinkaari 5E , 00790 Helsinki , Finland.
The Solubility Company , Viikinkaari 6 , 00790 Helsinki , Finland.
Anal Chem. 2019 Mar 19;91(6):3997-4003. doi: 10.1021/acs.analchem.8b05290. Epub 2019 Mar 4.
Solubility is a physicochemical property highly dependent on the solid-state form of a compound. Thus, alteration of a compound's solid-state form can be undertaken to enhance the solubility of poorly soluble drug compounds. In the Biopharmaceutics Classification System (BCS), drugs are classified on the basis of their aqueous solubility and permeability. However, aqueous solubility does not always correlate best with in vivo solubility and consequently bioavailability. Therefore, the use of biorelevant media is a more suitable approach for mimicking in vivo conditions. Here, assessed with a novel image-based single-particle-analysis (SPA) method, we report a constant ratio of solubility increase of 3.3 ± 0.5 between the α and γ solid-state forms of indomethacin in biorelevant media. The ratio was independent of pH, ionic strength, and surfactant concentration, which all change as the drug passes through the gastrointestinal tract. On the basis of the solubility ratio, a free-energy difference between the two polymorphic forms of 2.9 kJ/mol was estimated. Lastly, the use of the SPA approach to assess solubility has proven to be simple, fast, and both solvent- and sample-sparing, making it an attractive tool for drug development.
溶解度是一个高度依赖于化合物固态形式的物理化学性质。因此,可以改变化合物的固态形式来提高难溶性药物化合物的溶解度。在生物药剂学分类系统(BCS)中,药物是根据其水溶解度和渗透性来分类的。然而,水溶解度并不总是与体内溶解度和生物利用度最好相关。因此,使用生物相关介质是模拟体内条件的更合适方法。在这里,我们使用一种新的基于图像的单颗粒分析(SPA)方法评估了吲哚美辛在生物相关介质中α和γ固态形式之间溶解度增加的恒定比例为 3.3 ± 0.5。该比例不受 pH 值、离子强度和表面活性剂浓度的影响,这些因素在药物通过胃肠道时都会发生变化。基于溶解度比,估计两种多晶型形式之间的自由能差为 2.9 kJ/mol。最后,SPA 方法用于评估溶解度已被证明是简单、快速的,并且节省溶剂和样品,使其成为药物开发的有吸引力的工具。